$11.13
Today
as of Jul 22, 16:50 ET
Last 30 days
Recent Press Releases & News
ImmuCell Posts Strong Preliminary Q2 Sales on U.S. Demand
ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results
ICCC's Valuation Remains Premium: Is it Worth Overpaying for?
Overview
52-week range
$4.52
$11
100% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-1.2%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $0.21 | — | — | +31.2% | -1.2% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.02 | — | — | — | — | financials |
| Thu Aug 14, 2025 | Jun/2025 | $0.06 | — | — | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $0.16 | — | — | — | -1.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.09 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.20 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.06 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.12 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.18 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 13, 2026 | Jun/2026 | OTHER | — | $0.06 |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $6M | $8M | — | $6M | $5M |
| Cost of revenue | $6M | — | $3M | — | $5M | — | $4M | — |
| Gross profit | $5M | — | $2M | $3M | $3M | — | $2M | $1M |
| Operating income | $2M | — | $20,075 | $569,562 | $1M | — | $-574,894 | $-1M |
| Net income | $2M | — | $-139,748 | $501,880 | $1M | — | $-701,690 | $-2M |
| EPS (diluted) | $0.21 | — | $-0.02 | $0.06 | $0.16 | — | $-0.09 | $-0.20 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $7M | $4M | $4M | — | — | $4M | — | $1M |
| Inventory | $9M | $9M | $10M | $8M | $7M | $7M | $7M | $7M |
| Total current assets | $19M | $17M | $17M | $17M | $16M | $15M | $14M | $11M |
| Total assets | $44M | $43M | $46M | $47M | $46M | $45M | $44M | $42M |
| Long-term debt | $7M | $7M | $8M | $8M | — | $9M | — | — |
| Total liabilities | $15M | $15M | $16M | $17M | $17M | $18M | $18M | $18M |
| Total equity | $29M | $27M | $30M | $30M | $29M | $28M | $26M | $23M |
Implied volatility — last 90 days
No IV snapshots yet for ICCC.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.